ES8305333A1 - "procedimiento para la preparacion de nuevas sulfiminas". - Google Patents

"procedimiento para la preparacion de nuevas sulfiminas".

Info

Publication number
ES8305333A1
ES8305333A1 ES514275A ES514275A ES8305333A1 ES 8305333 A1 ES8305333 A1 ES 8305333A1 ES 514275 A ES514275 A ES 514275A ES 514275 A ES514275 A ES 514275A ES 8305333 A1 ES8305333 A1 ES 8305333A1
Authority
ES
Spain
Prior art keywords
procedure
formula
reaction
sulfimines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES514275A
Other languages
English (en)
Spanish (es)
Other versions
ES514275A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES514275A0 publication Critical patent/ES514275A0/es
Publication of ES8305333A1 publication Critical patent/ES8305333A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
ES514275A 1981-07-25 1982-07-23 "procedimiento para la preparacion de nuevas sulfiminas". Expired ES8305333A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813129444 DE3129444A1 (de) 1981-07-25 1981-07-25 "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel"

Publications (2)

Publication Number Publication Date
ES514275A0 ES514275A0 (es) 1983-04-01
ES8305333A1 true ES8305333A1 (es) 1983-04-01

Family

ID=6137766

Family Applications (4)

Application Number Title Priority Date Filing Date
ES514275A Expired ES8305333A1 (es) 1981-07-25 1982-07-23 "procedimiento para la preparacion de nuevas sulfiminas".
ES518826A Expired ES8400410A1 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.
ES518827A Granted ES518827A0 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.
ES518828A Granted ES518828A0 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES518826A Expired ES8400410A1 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.
ES518827A Granted ES518827A0 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.
ES518828A Granted ES518828A0 (es) 1981-07-25 1983-01-07 Procedimiento para la preparacion de nuevas sulfiminas.

Country Status (19)

Country Link
JP (1) JPS5824559A (enExample)
KR (1) KR840000491A (enExample)
AR (1) AR230745A1 (enExample)
AU (1) AU556082B2 (enExample)
CA (1) CA1175430A (enExample)
CS (1) CS236488B2 (enExample)
DD (1) DD202871A5 (enExample)
DE (2) DE3129444A1 (enExample)
DK (1) DK329582A (enExample)
ES (4) ES8305333A1 (enExample)
FI (1) FI822550A7 (enExample)
GR (1) GR76181B (enExample)
HU (1) HU188188B (enExample)
NO (1) NO822255L (enExample)
PL (1) PL137725B1 (enExample)
PT (1) PT75297A (enExample)
SU (1) SU1158041A3 (enExample)
YU (1) YU158182A (enExample)
ZA (1) ZA825273B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7863283B2 (en) * 2008-01-17 2011-01-04 Bayer Schering Pharma Ag Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments

Also Published As

Publication number Publication date
ES8400412A1 (es) 1983-10-16
ZA825273B (en) 1984-03-28
SU1158041A3 (ru) 1985-05-23
ES8400411A1 (es) 1983-10-16
AU556082B2 (en) 1986-10-23
ES518826A0 (es) 1983-10-16
CS236488B2 (en) 1985-05-15
AU8637882A (en) 1983-04-14
PL137725B1 (en) 1986-07-31
PL237600A1 (en) 1983-03-28
ES514275A0 (es) 1983-04-01
FI822550A0 (fi) 1982-07-20
HU188188B (en) 1986-03-28
KR840000491A (ko) 1984-02-22
FI822550L (fi) 1983-01-26
ES8400410A1 (es) 1983-10-16
JPS5824559A (ja) 1983-02-14
DD202871A5 (de) 1983-10-05
ES518827A0 (es) 1983-10-16
FI822550A7 (fi) 1983-01-26
YU158182A (en) 1984-08-31
AR230745A1 (es) 1984-06-29
ES518828A0 (es) 1983-10-16
PT75297A (fr) 1982-08-01
DE3246980A1 (de) 1984-06-20
NO822255L (no) 1983-01-26
GR76181B (enExample) 1984-08-03
DE3129444A1 (de) 1983-02-10
CA1175430A (en) 1984-10-02
DK329582A (da) 1983-01-26

Similar Documents

Publication Publication Date Title
ES8608874A1 (es) Un procedimiento para la preparacion de una 2-(1h)-quinolona
ES8306156A1 (es) Un procedimiento para la produccion de nuevas cefalosporinas.
ES8801642A1 (es) Un procedimiento para la preparacion de l,2,4-triazoles
ES8506696A1 (es) Un procedimiento para la preparacion de 1-(4-(4,4-dialquil-2,6-piperidindion-1-il)butil)piperazinas.
ES8704872A1 (es) Un procedimiento para preparar aril-hidroxamatos
ES8704924A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
ES8607955A1 (es) Procedimiento para preparar nuevos derivados tetrazolicos deacidos grasos insaturados
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8301980A1 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8304987A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8707239A1 (es) Procedimiento para preparar nuevos derivados imidazo.
ES8604529A1 (es) Un procedimiento para la preparacion de 1-(4 pirimidiniloxi)-3(heterilalquilamino)-2-propanoles.
ES8301965A1 (es) Procedimiento para preparar derivados de acido quinolina- carboxilico
ES8307774A1 (es) Un procedimiento para la preparacion de nuevos derivados de diaminosotiazol.
ES8305718A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
ES8704503A1 (es) Procedimiento para preparar sales de ciclimonio
ES8205837A1 (es) Un procedimiento para la produccion de derivados de halogeno-triacinilo.
ES8604162A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8307792A1 (es) Un metodo de produccion de compuesto de dihidropiridina.
ES8704468A1 (es) Procedimiento para preparar nuevos 1,2,4-triazolo-carbamatos
ES8606321A1 (es) Un procedimiento para preparar un derivado de 2-hidroxi-3- (4-fenilpiperazimil)propoxi-benzofurano
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas